Person-centred care provided by a multidisciplinary primary care team to improve therapeutic adequacy in polymedicated elderly patients (PCMR): randomised controlled trial protocol

dc.contributor.author
Rovira, Carol
dc.contributor.author
Modamio Charles, Pilar
dc.contributor.author
Pascual, Joaquim
dc.contributor.author
Armengol, Joan (Armengol Bachero)
dc.contributor.author
Ayala, Cristian
dc.contributor.author
Gallego, Joan
dc.contributor.author
Mariño Hernández, Eduardo L.
dc.contributor.author
Ramirez, Anna
dc.date.accessioned
2026-01-27T06:28:00Z
dc.date.available
2026-01-27T06:28:00Z
dc.date.issued
2026-01-26T09:20:09Z
dc.date.issued
2026-01-26T09:20:09Z
dc.date.issued
2022
dc.date.issued
2026-01-26T09:20:09Z
dc.identifier
2044-6055
dc.identifier
https://hdl.handle.net/2445/226122
dc.identifier
717572
dc.identifier.uri
https://hdl.handle.net/2445/226122
dc.description.abstract
Introduction The increase in elderly population has led to an associated increase in multiple pathologies, frailty, polypharmacy, healthcare costs, decreased quality of life and mortality. We designed an intervention based on person- centred care model. This article outlines a study protocol, which aims to explore the effects of the intervention to improve therapeutic adequacy in polymedicated elderly patients. Methods and analysis An open, randomised, multicentre, controlled clinical trial. The study population includes polymedicated (≥8 prescription medications) patients ≥75 years old. In the intervention group, the multidisciplinary team (primary care pharmacist, family doctor and nurse) will meet to carry out multidimensional reviews (frailty, clinical complexity, morbidity and therapeutic adequacy) of the study subjects. If changes are proposed to the treatment plan, a clinical interview will be conducted with the patient to agree on changes in accordance with their preferences. Follow- up visits will be scheduled at 6 and 12 months. In the control group, where the usual clinical practice will be followed, the necessary data will be collected to compare the results. The key variables are the variation in the mean number of incidents (potentially inappropriate prescription) per patient, the number of medications, the number of changes implemented to the treatment plan and the variation in the number of hospital admissions. Ethics and dissemination This study was approved by the Ethics Committee of the IDIAPJGol and by the University of Barcelona’s Bioethics Commission. The results are expected to be published in peer reviewed open- access journals, and as part of a doctoral thesis. Trial registration number NCT04188470. Pre- results.
dc.format
10 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BMJ Publishing Group
dc.relation
Reproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-051238
dc.relation
BMJ Open, 2022, vol. 12, p. e051238
dc.relation
https://doi.org/10.1136/bmjopen-2021-051238
dc.rights
cc-by (c) Rovira, Carol et al., 2022
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Atenció primària
dc.subject
Persones grans
dc.subject
Medicaments
dc.subject
Primary care
dc.subject
Older people
dc.subject
Drugs
dc.title
Person-centred care provided by a multidisciplinary primary care team to improve therapeutic adequacy in polymedicated elderly patients (PCMR): randomised controlled trial protocol
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)